tiprankstipranks
Mitchell Kapoor Reaffirms Buy Rating for Summit Therapeutics Amid Promising Ivonescimab Trial Results
PremiumRatingsMitchell Kapoor Reaffirms Buy Rating for Summit Therapeutics Amid Promising Ivonescimab Trial Results
6d ago
Positive Phase 3 Trial Results for Ivonescimab Boost Confidence in Summit Therapeutics’ NSCLC Prospects
Premium
Ratings
Positive Phase 3 Trial Results for Ivonescimab Boost Confidence in Summit Therapeutics’ NSCLC Prospects
7d ago
Akeso reports results from HARMONi-6 Phase III clinical trial
Premium
The Fly
Akeso reports results from HARMONi-6 Phase III clinical trial
7d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100